Commercial International Bank (Egypt) S.A.E. |
||||
Consolidated Financial Statements
March 31, 2023 |
||||
Click on, or paste the following link into your web browser, to view the associated PDF document.
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim Cash flows for the period ended March 31 2023
|
||||
|
|
|
|
|
|
Notes |
Mar. 31, 2023 |
|
Mar. 31, 2022 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
Profit before income tax from continued operations |
|
8,975,279 |
|
6,142,091 |
Profit from discontinued operations |
|
870 |
|
- |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
|
|
Fixed assets depreciation |
16 |
228,065 |
|
223,781 |
Impairment (Released) charge for credit losses (Loans and advances to customers and banks) |
|
707,740 |
|
(145,266) |
Other provisions charges |
21 |
464,311 |
|
1,036,252 |
Impairment (Released) charge for credit losses (due from banks) |
|
2,096 |
|
4,776 |
Impairment (Released) charge for credit losses (financial investments) |
|
234,993 |
|
101,798 |
Impairment (Released) charge for other assets |
|
- |
|
(277,768) |
Exchange revaluation differences for financial assets at fair value through OCI and AC |
|
(6,033,831) |
|
63 |
Goodwill amortization |
26 |
10,314 |
|
10,314 |
Intangible assets amortization |
27 |
2,591 |
|
2,591 |
Utilization of other provisions |
21 |
(345) |
|
(156) |
Other provisions no longer used |
21 |
- |
|
(385) |
Exchange differences of other provisions |
21 |
1,169,894 |
|
278,463 |
profits from selling property and equipment |
|
(118) |
|
(50) |
profits from selling financial investments at fair value through OCI |
13 |
(70,920) |
|
(1,040,297) |
Shares based payments |
|
190,974 |
|
175,235 |
Bank's share in the profits / losses of associates |
|
14,871 |
|
(2,841) |
Operating profits before changes in operating assets and liabilities |
|
5,896,784 |
|
6,508,601 |
|
|
|
|
|
Net decrease (increase) in assets and liabilities |
|
|
|
|
Due from banks |
|
12,110,117 |
|
25,468,271 |
Financial assets at fair value through P&L |
|
- |
|
239,339 |
Derivative financial instruments |
|
(359,998) |
|
(680,085) |
Loans and advances to banks and customers |
11 - 12 |
(17,792,410) |
|
(12,821,977) |
Other assets |
|
(96,139) |
|
1,844,416 |
Non current assets held for sale |
|
(220,335) |
|
- |
Due to banks |
17 |
4,790,187 |
|
2,859,939 |
Due to customers |
18 |
45,212,196 |
|
21,780,515 |
Current income tax obligations paid |
|
(270,197) |
|
(259,516) |
Non current liabilities held for sale |
|
890 |
|
- |
Other liabilities |
|
(354,332) |
|
1,860,904 |
Net cash generated from (used in) operating activities |
|
48,916,763 |
|
46,800,407 |
|
|
|
|
|
Cash flow from investing activities |
|
|
|
|
Payment for purchases of property, equipment and branches constructions |
|
(457,850) |
|
(92,999) |
Proceeds from selling property and equipment |
|
118 |
|
50 |
Proceeds from redemption of financial assets at amortized cost |
|
196,783 |
|
2,609,283 |
Payment for purchases of financial assets at amortized cost |
|
(8,533,818) |
|
(2,474,553) |
Payment for purchases of financial assets at fair value through OCI |
|
(32,339,905) |
|
(68,625,535) |
Proceeds from selling financial assets at fair value through OCI |
|
46,767,421 |
|
78,456,150 |
Payment for investment in subsidiaries. |
|
(1,008,761) |
|
- |
Net cash generated from (used in) investing activities |
|
4,623,988 |
|
9,872,396 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Condensed Consolidated Interim Cash flows for the period ended March 31, 2023 (Cont.)
|
||||
|
|
|
|
|
|
|
Mar. 31, 2023 |
|
Mar. 31, 2022 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from financing activities |
|
|
|
|
Other loans |
|
1,607,404 |
|
1,035,994 |
Dividends paid |
|
(1,988,585) |
|
(4,410,322) |
Issued debt instruments |
|
612,624 |
|
253,338 |
Capital increase |
|
165,429 |
|
122,716 |
Net cash generated from (used in) financing activities |
|
396,872 |
|
(2,998,274) |
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalent during the period |
|
53,937,623 |
|
53,674,529 |
Beginning balance of cash and cash equivalent |
|
92,969,526 |
|
61,065,822 |
Cash and cash equivalent at the end of the period |
|
146,907,149 |
|
114,740,351 |
|
|
|
|
|
Cash and cash equivalent comprise: |
|
|
|
|
Cash and balances at the central bank |
|
52,462,528 |
|
30,581,505 |
Due from banks |
|
170,733,811 |
|
121,128,084 |
Treasury bills and other governmental notes |
10 |
68,681,151 |
|
40,379,000 |
Obligatory reserve balance with CBE |
|
(46,005,523) |
|
(26,188,639) |
Due from banks with maturities more than three months |
|
(29,664,721) |
|
(10,245,456) |
Treasury bills with maturity more than three months |
|
(69,300,097) |
|
(40,914,143) |
Total cash and cash equivalent |
|
146,907,149 |
|
114,740,351 |
'
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2022 |
|
|
|
|
|||||||||||
Mar. 31, 2022 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders Equity |
Non Controlling Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands |
|
Beginning balance |
19,702,418 |
3,293,074 |
28,260,532 |
1,550,906 |
8,183 |
16,000 |
641,372 |
9,141 |
13,696,402 |
1,674,392 |
(4,218) |
68,848,202 |
454,535 |
69,302,737 |
|
Capital increase |
122,716 |
- |
502,922 |
- |
- |
- |
- |
- |
- |
(502,922) |
- |
122,716 |
- |
122,716 |
|
Transferred to reserves |
- |
670,872 |
8,333,404 |
- |
- |
2,947 |
- |
- |
(9,007,223) |
- |
- |
- |
- |
- |
|
Dividends paid |
- |
- |
- |
- |
- |
- |
- |
- |
(4,410,322) |
- |
- |
(4,410,322) |
- |
(4,410,322) |
|
Net profit of the period |
- |
- |
- |
- |
- |
- |
- |
- |
4,244,231 |
- |
- |
4,244,231 |
15,387 |
4,259,618 |
|
Transferred to RE from financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(4,201) |
- |
4,201 |
- |
- |
- |
- |
- |
|
Net unrealized gain/(loss) on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
- |
(3,961,167) |
- |
- |
- |
- |
(3,961,167) |
- |
(3,961,167) |
|
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
2,840 |
(2,840) |
- |
- |
- |
- |
- |
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
- |
101,602 |
- |
- |
- |
- |
101,602 |
- |
101,602 |
|
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
175,235 |
- |
175,235 |
- |
175,235 |
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
56,854 |
56,854 |
39,279 |
96,133 |
|
Balance at the end of the period |
19,825,134 |
3,963,946 |
37,096,858 |
1,550,906 |
8,183 |
18,947 |
(3,222,394) |
11,981 |
4,524,449 |
1,346,705 |
52,636 |
65,177,351 |
509,201 |
65,686,552 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2023
|
|
|
|
|
|||||||||||
|
|
|
|
|
|||||||||||
Mar. 31, 2023 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders Equity |
Non Controlling Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands |
|
Beginning balance |
29,825,134 |
3,963,946 |
27,096,858 |
1,550,906 |
8,183 |
18,947 |
(13,188,818) |
11,981 |
16,393,841 |
1,895,435 |
181,324 |
67,757,737 |
580,431 |
68,338,168 |
|
Capital increase |
165,429 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
165,429 |
- |
165,429 |
|
Transferred to reserves |
- |
806,408 |
11,998,639 |
- |
- |
2,208 |
- |
- |
(12,388,223) |
(419,032) |
- |
- |
- |
- |
|
Dividends paid |
- |
- |
- |
- |
- |
- |
- |
- |
(3,738,888) |
- |
- |
(3,738,888) |
(23,982) |
(3,762,870) |
|
Net profit of the period |
- |
- |
- |
- |
- |
- |
- |
- |
6,064,947 |
- |
- |
6,064,947 |
3,847 |
6,068,794 |
|
Transferred to RE from financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(1,895) |
- |
1,895 |
- |
- |
- |
- |
- |
|
Change in non controlling interest from acquisition of subsidiaries |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
(536,867) |
(536,867) |
|
Reserve for transactions under common control |
- |
- |
- |
- |
(679,155) |
- |
- |
- |
- |
- |
- |
(679,155) |
- |
(679,155) |
|
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
- |
(8,522,293) |
- |
- |
- |
- |
(8,522,293) |
- |
(8,522,293) |
|
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
3,249 |
(3,249) |
- |
- |
- |
- |
- |
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
- |
208,752 |
- |
- |
- |
- |
208,752 |
- |
208,752 |
|
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
190,974 |
- |
190,974 |
- |
190,974 |
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
100,603 |
100,603 |
99,192 |
199,795 |
|
Balance at the end of the period
|
29,990,563 |
4,770,354 |
39,095,497 |
1,550,906 |
(670,972) |
21,155 |
(21,504,254) |
15,230 |
6,330,323 |
1,667,377 |
281,927 |
61,548,106 |
122,621 |
61,670,727 |
|